Market Overview

Morning Market Movers

Related OMED
OncoMed Presents Positive Immuno-Oncology Data for Combined Blockade of DLL4, VEGF and PD1 at SITC Conference
Biotech Investors Still Have Opportunity
Related CELG
3 Top Biotech Stocks See Their Short Interest Plunge
Must Watch Stocks for November 5, 2015
The New Diversification - Cramer's Mad Money (11/25/15) (Seeking Alpha)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (CELG + CNAT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters